Legislation


HB 267 (see companion bill SB 1328) – Hawaii

Status: Inactive / Dead
Year Introduced: 2019
Link: https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=HB&billnumber=267&year=2019

Requires drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a sixteen per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame. Effective 7/1/2050. (SD1)


Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found